Pharmaceuticals

Global Insomnia Therapeutics Market Revenue and Share Analysis Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the insomnia therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Insomnia Therapeutics Market In The Period 2029-2034?

The insomnia therapeutics market has experienced significant expansion over recent years. Projections show its value will increase from $3.03 billion in 2024 to $3.2 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.7%. This historic growth is attributable to the increasing prevalence of insomnia, greater awareness concerning sleep disorders, the growing adoption of cognitive behavioral therapy for insomnia (CBT-I), an expansion of available pharmaceutical treatments, and the rising consumption of over-the-counter sleep aids.

The insomnia therapeutics market is anticipated to show significant expansion over the upcoming years, projected to reach $3.98 billion by 2029, with a compound annual growth rate (CAGR) of 5.6%. This expected growth during the forecast period stems from progress in AI-powered sleep monitoring, a rising demand for tailored medical treatments, an expanding elderly demographic experiencing sleep disorders, greater awareness regarding mental health, and a broadening array of innovative insomnia medications under development. Prominent trends for this period encompass the incorporation of digital therapeutics into insomnia care, a growing inclination towards non-pharmacological interventions, the increasing use of wearable devices for sleep tracking, the formulation of advanced sleep medications, and the expansion of telemedicine options for managing sleep disturbances.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp

What Strategic Drivers Are Accelerating The Insomnia Therapeutics Market Expansion?

Elevated stress levels and evolving lifestyles are anticipated to drive the future expansion of the insomnia therapeutics market. These factors encompass psychological and behavioral shifts in daily routines and responsibilities, which contribute to emotional strain and disrupted sleep patterns. The escalation of stress and changes in lifestyle are fueled by constant digital connectivity, which blurs work-life boundaries and limits opportunities for genuine mental rejuvenation. Insomnia therapeutics plays a critical role by offering effective, scientifically supported treatment solutions designed to restore healthy sleep, alleviate sleep-related anxiety, and bolster mental well-being in the face of modern stressors. For instance, in May 2024, the American Psychiatric Association (APA), a US-based organization of psychiatrists, reported that the proportion of U.S. adults feeling more anxious increased from 32% in 2022 to 37% in 2023, reaching 43% in 2024. Thus, escalating stress and lifestyle transformations are significantly contributing to the growth of the insomnia therapeutics market.

What Is The Detailed Segment Distribution Of The Insomnia Therapeutics Market?

The insomnia therapeutics market covered in this report is segmented –

1) By Treatment Type: Drugs, Medical Devices

2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches

3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers

Subsegments:

1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs

2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices

How Are Global Trends Impacting The Development Of The Insomnia Therapeutics Market?

Leading companies in the insomnia therapeutics market are concentrating on developing advanced treatments such as dual orexin receptor antagonists (DORAs) to provide targeted therapeutic options with fewer adverse effects and improved safety profiles. A DORA is a category of medication that inhibits both orexin-1 and orexin-2 receptors in the brain to facilitate sleep by suppressing the wakefulness signaling pathway, frequently utilized in insomnia management. For instance, in June 2023, Idorsia Pharmaceuticals Ltd., a Switzerland-based pharmaceutical company, introduced QUVIVIQ (daridorexant), a pioneering dual orexin receptor antagonist (DORA) for the treatment of chronic insomnia disorder. This therapy is engineered to diminish nighttime wakefulness without disrupting natural sleep architecture, thereby offering patients enhanced sleep onset, maintenance, and daytime functioning. Its approval signifies a considerable step forward in insomnia treatment, presenting a precise mechanism of action distinct from conventional sedative-hypnotics and addressing the outstanding need for long-term, non-habit-forming therapeutic solutions.

Who Are The Major Stakeholders Operating In The Insomnia Therapeutics Market?

Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., Cerêve Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Insomnia Therapeutics Market?

North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24255&type=smp

Browse Through More Reports Similar to the Global Insomnia Therapeutics Market 2025, By The Business Research Company

Therapeutic Dental Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795